Opioid Stewardship Programs: Prescribing Defaults, PDMP Checks, and Naloxone Triggers

An opioid stewardship program is the set of policies, order-set defaults, and monitoring workflows a hospital runs to keep opioid prescribing appropriate to the clinical situation — effective for the patient’s pain, and no larger or longer than the episode of care requires. It sits alongside, but is distinct from, three programs it’s frequently confused with: antimicrobial stewardship (a different drug class with its own CDC Core Elements framework), a drug-specific REMS (an FDA-mandated risk mitigation strategy tied to a specific product’s approval, not a hospital-run program), and adverse drug event surveillance (retrospective detection of harm that already occurred, using naloxone administration as one trigger among several). Opioid stewardship is upstream of all three: it shapes the prescribing decision itself, before an event has anything to detect.

This guide sets out the program elements — procedure-based prescribing defaults, PDMP-check integration, naloxone co-prescribing triggers, and governance metrics — that build teams typically stand up. The core clinical thresholds referenced below (the caution and avoid-without-justification morphine milligram equivalent, or MME, bands, and the risk factors that should trigger a naloxone offer) reflect the framework of the CDC’s 2022 Clinical Practice Guideline for Prescribing Opioids for Pain as it is widely taught and cited in hospital pharmacy and patient-safety literature; cdc.gov itself returned an access error to automated retrieval during this review, so confirm the current guideline text directly before finalizing exact numeric thresholds in a written policy. Joint Commission pain-management standard citations are similarly not independently confirmed against the primary accreditation manual (jointcommission.org is not reachable to automated tools) — verify the current Provision of Care chapter language with your accreditation team before citing a specific standard number in policy documents.

What an Opioid Stewardship Program Actually Governs

A stewardship program’s job is to make the safe choice the default choice at four decision points: how much and for how long to prescribe for a given clinical scenario, whether the prescriber has checked what else the patient is already taking, whether a rescue medication should go home with the patient, and whether non-opioid options were tried first. None of that requires banning opioids or imposing a hard dose ceiling — the CDC’s 2022 guideline explicitly moved away from a one-size-fits-all MME cap toward individualized therapy, framing specific MME/day thresholds as points requiring added caution and justification rather than hard stops. A hospital program translates that individualized judgment into defaults clinicians don’t have to reconstruct from memory at 2 a.m.

Prescribing Guidelines by Procedure Type

The highest-yield stewardship intervention most hospitals implement first is procedure-specific default quantities built into surgical order sets, rather than a single opioid-naive quantity applied to every discharge. The pattern most programs converge on:

• Minor/low-pain procedures (e.g., simple laparoscopic cases, minor orthopedic procedures) — a short default course, often 0–3 days’ supply, with non-opioid analgesia (scheduled acetaminophen/NSAID, unless contraindicated) as the first-line order, opioids reserved as a breakthrough option rather than the default.
• Moderate-pain procedures (e.g., open abdominal surgery, joint procedures without major tissue disruption) — a defined short course, typically in the 3–5 day range, reassessed at follow-up rather than auto-refilled.
• Major/high-pain procedures and trauma — individualized therapy with closer follow-up, multimodal analgesia built in from the first order rather than added after a complaint of inadequate pain control, and an explicit taper plan documented before discharge.
• Chronic pain / long-term therapy — outside the scope of a single procedure-based default; these patients need the ongoing-monitoring elements below (periodic PDMP re-checks, risk reassessment, and a documented risk-benefit review) rather than a fixed initial-course default.

The mechanism that makes this stick isn’t a policy document — it’s building the defaults into the EHR order set itself, so the safer quantity is what a prescriber sees first and has to actively override, not something they’d need to look up. Programs that publish the guideline as a PDF but never touch the order set see prescribing patterns barely move; programs that change the order-set default see it move immediately, because most prescriptions follow whatever number is pre-populated.

PDMP-Check Integration

A prescription drug monitoring program (PDMP) is the state-run database of controlled-substance dispensing records that lets a prescriber see what a patient has already been prescribed and filled, across pharmacies and prescribers, before adding another opioid order. Most states now require a PDMP query before an initial opioid prescription and at defined intervals during ongoing therapy, though the exact trigger conditions and query frequency are set at the state level and vary — confirm your state’s specific mandatory-query law rather than assuming a national standard, since there isn’t one.

The stewardship-program design question isn’t whether to check the PDMP — state law usually already answers that — it’s where the check happens in the workflow. The two integration patterns hospitals use:

• EHR-embedded query at the point of prescribing — the PDMP result (or a summary/risk score, where the state’s PDMP vendor supports one) surfaces inside the order screen itself, ideally via a direct interface between the EHR and the state PDMP rather than a separate login. This is the pattern with the highest actual compliance, because it removes the extra step of leaving the chart to check a second system.
• Standalone portal query, documented back into the chart — the prescriber (or a delegate, where state law permits delegation) logs into the state PDMP portal separately and documents that the check occurred. This works but has materially lower real-world compliance than EHR-embedded query, because it depends on the prescriber remembering to do it outside their normal ordering flow.

Whichever pattern a hospital uses, a stewardship program should be able to report what percentage of new opioid orders have a documented PDMP check attached — that’s the single most defensible process metric for demonstrating the program is functioning, separate from any outcome measure.

Naloxone Co-Prescribing Triggers

Naloxone co-prescribing means the opioid prescription and a naloxone prescription (or take-home kit) are offered together, with patient/caregiver education on when and how to use it, rather than treating naloxone as something only an opioid-treatment or harm-reduction program provides. The CDC’s 2022 guideline frames this as something clinicians should consider offering when risk factors for overdose are present, rather than for every opioid prescription — the risk factors most consistently cited in the clinical literature and reflected in hospital naloxone-co-prescribing protocols are:

• A history of opioid overdose, regardless of how remote.
• A current or past substance use disorder involving any substance, not only opioids.
• Higher-dose opioid therapy — commonly operationalized in hospital protocols around a 50 MME/day threshold, consistent with where the CDC guideline places its first caution point.
• Concurrent benzodiazepine (or other CNS depressant/sedative) use, which compounds respiratory-depression risk independent of the opioid dose itself.
• Known respiratory conditions (e.g., significant COPD, sleep apnea) that independently elevate overdose risk at a given dose.

A stewardship program’s job is to turn “consider offering” into a concrete, auditable trigger: a best-practice advisory or hard stop in the EHR that fires when an opioid order meets one or more of the criteria above, prompting the prescriber to either add the naloxone order or document why it isn’t being offered. Left as a general recommendation with no system-level trigger, naloxone co-prescribing rates for at-risk patients tend to stay low even when every clinician would agree, if asked directly, that it’s the right thing to do — the gap is almost always a workflow gap, not a knowledge gap.

Governance and Metrics

A functioning program has a named committee or subcommittee (often reporting through pharmacy and therapeutics or the broader medication-safety committee referenced on CASRAI’s high-alert medications guide, since opioids sit on essentially every hospital’s ISMP high-alert list) with a standing dashboard, not a one-time policy rollout. Metrics that separate a real program from a paper one:

• Process measures — percentage of new opioid orders with a documented PDMP check; percentage of orders meeting risk criteria with a naloxone co-prescription or documented decline; adherence of discharge quantities to the procedure-based defaults above.
• Utilization measures — average MME/patient-day by service line, trended over time; opioid-naive patients discharged on doses above the procedure-specific default.
• Outcome and regulatory measures — the CMS Hospital Inpatient Quality Reporting program’s Safe Use of Opioids — Concurrent Prescribing eCQM (CMS506v8) is already a required measure in the current reporting period, and Hospital Harm — Opioid-Related Adverse Events (CMS819v4) is finalized to join the required eCQM set for the CY2027 reporting period — a stewardship program’s metrics should track ahead of that reporting requirement, not scramble to build the workflow once it’s mandatory. See CASRAI’s eCQM reporting guide for how these measures are scored and where they most often fail on documentation rather than actual care.

Because opioids are Schedule II–V controlled substances, program governance also intersects with procurement and diversion-control obligations that sit outside clinical policy — see CASRAI’s DEA controlled-substance storage requirements guide for the physical-security and recordkeeping side of the same drug class.

Building the Program: A Practical Sequence

1. Charter a committee with explicit authority over order-set content, not just an advisory role — a stewardship program with no ability to change the EHR defaults will produce recommendations, not results.
2. Baseline the current state before changing anything: current MME/patient-day by service, current PDMP-check documentation rate, current naloxone co-prescribing rate among patients who’d meet the risk criteria above. Without a baseline, the program can’t show it changed anything.
3. Redesign order sets around the procedure-based defaults, working with surgical and ED service-line leadership rather than issuing the change from pharmacy alone — adoption is consistently better when the ordering clinicians helped set the default.
4. Integrate the PDMP check and the naloxone trigger into the EHR workflow, not just into a policy PDF — this is usually the longest step, since it typically requires IT/informatics build time and, for PDMP integration specifically, coordination with the state PDMP administrator on the interface.
5. Train and communicate before go-live, framing the change as making the safe default easier to follow, not as a restriction on clinical judgment — individualized therapy above the defaults remains appropriate and should stay easy to document, not buried behind extra clicks.
6. Report on a standing cadence — monthly or quarterly dashboard review by the committee, with the process and utilization metrics above, and a clear owner for each metric that’s trending the wrong way.

Frequently Asked Questions

Is a hospital opioid stewardship program legally required?

There is no single federal mandate requiring a hospital to operate a formally named “opioid stewardship program,” but the underlying components are effectively required piecemeal: PDMP-check laws exist in most states, CMS eCQM reporting already includes an opioid-prescribing measure, and Joint Commission accreditation standards address pain management and high-risk medication safety more broadly (confirm current standard language with your accreditation team, since the primary manual could not be independently verified for this guide). Most hospitals build a named program specifically to organize compliance with those separate requirements under one governance structure, rather than because a single rule requires the program by that name.

Does every opioid prescription need a naloxone co-prescription?

No. The guidance is to offer naloxone when specific risk factors are present — prior overdose, substance use disorder history, higher-dose therapy, concurrent sedative use, or relevant respiratory conditions — not as a universal default attached to every opioid order. A well-built stewardship program automates that risk check so it isn’t left to individual clinician recall.

How is opioid stewardship different from antimicrobial stewardship?

They share a governance pattern (committee, order-set defaults, monitoring, dashboard metrics) but govern different risk. Antimicrobial stewardship manages resistance and treatment-failure risk from overuse across an entire drug class; see CASRAI’s antimicrobial stewardship guide for the CDC Core Elements framework it follows. Opioid stewardship manages overdose, diversion, and dependence risk, and layers in controlled-substance-specific obligations (PDMP checks, DEA storage/recordkeeping) that antimicrobial stewardship doesn’t carry.

What’s the difference between PDMP checking and REMS compliance?

A PDMP check is a state-mandated look at a patient’s controlled-substance history before prescribing; it’s about that specific patient’s current risk. A REMS is an FDA-required risk mitigation strategy tied to a specific drug product’s approval, which can include prescriber certification, patient enrollment, or pharmacy dispensing restrictions. Most standard opioid formulations used in a hospital do not carry an individual product REMS, but the opioid class as a whole is subject to an FDA opioid-analgesic REMS education requirement for prescribers — the two obligations run in parallel and a stewardship program needs to track both, not substitute one for the other.

Return to the patient safety pillar for the full set of hospital patient-safety and infection-prevention guides.